| abstract |
The present invention relates to the management of diseases in which it is beneficial to increase glucokinase activity, such as, for example, diseases such as IGT, X syndrome, type 2 diabetes, type 1 diabetes, dyslipidemia, hyperlipidemia, hypertension and obesity, A compound of formula (I) which is an active agent of glucokinase (GK) which may be useful for treatment, control or adjuvant therapy. |